Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for central nervous system disorders.
- Year invested 2017
- Investment Stage Public/PIPES
- Sectors
- Investment Status Historic
- Associated Team
- Website addextherapeutics.com/en/
- Company Status IPO/Public (NASDAQ/SIX: ADXN)